THE IPRO QIN-QIO INVITES YOU
TO PARTICIPATE IN OUR
Anticoagulation Learning Circle
- Anticoagulants (blood thinners) are important for preventing and treating blood clots but are associated with an increased risk for bleeding.
- Using anticoagulants safely requires a careful balance between risks and benefits.
- Among older adults, oral anticoagulants are the most common causes of adverse drug events (ADEs) leading to emergency room visits and emergent hospitalizations. Oral anticoagulants include warfarin and the direct-acting oral anticoagulants (DOACs) such as apixaban, dabigatran, edoxaban, and rivaroxaban.
- Bleeding from oral anticoagulants resulted in approximately 235,000 emergency department visits.
- Older adults (≥65 years of age) were involved in approximately 80% of DOAC-related bleeding visits and 77% of warfarin-related bleeding visits.
- DOACs contributed to approximately 40% of estimated oral anticoagulant bleeding visits. (bit.ly/45EFF8v)
|The Anticoagulation Learning Circle offers a forum for education and sharing of resources and best practices with a goal for all participants to benefit from the wisdom and experience of the group. |
Join other clinicians and a subject matter expert in conversations focused on anticoagulation stewardship.
|This Learning Circle will provide you the opportunity to:|
-Review anticoagulant Adverse Drug Events (ADEs) and associated risk factors.
-Discuss actual case studies from the practice of a specialist with experience in anticoagulation stewardship.
-Use a template Action Plan to assess anticoagulation management and evaluate outcome measures.
-Pose questions about anticoagulation stewardship to a subject matter expert.
ANTICOAGULATION LEARNING CIRCLE SCHEDULE
Wednesday, November 15, 2023 • 12:00 PM | (UTC-04:00) Eastern Time (US & Canada)
SUBJECT MATTER EXPERT:
Elizabeth Pogge, PharmD, MPH, BCPS, BCGP, FASCP
Professor, Pharmacy Practice – Midwestern University